Desmopressin is a medicine used to treat a condition that makes you pass a lot of urine (diabetes insipidus), bedwetting, and some bleeding disorders. It comes as a pill, a nasal spray, a liquid, or a shot. It works like a natural body hormone that helps your kidneys hold on to water and helps blood clot.
Every report comes from a Lived member, sent anonymously.
Have you tried DDAVP (Desmopressin) for Central Diabetes Insipidus?
Desmopressin, sold as DDAVP and under other names, is a man-made version of vasopressin, the body's antidiuretic hormone (the hormone that tells the kidneys to hold on to water). Its main use is central diabetes insipidus, a rare condition in which the brain does not release enough of this hormone, so a person passes very large amounts of watery urine and feels constantly thirsty. Despite the name, it is unrelated to the blood sugar disease diabetes mellitus. Desmopressin is also used for the temporary heavy urination that can follow a head injury or surgery near the pituitary gland. It does not help nephrogenic diabetes insipidus, where the kidneys themselves fail to respond to the hormone. Desmopressin tablets are approved for bedwetting in children 6 and older, on their own or alongside a bedwetting alarm and other behavioral approaches. The nasal spray is not approved for bedwetting, because it led to more cases of dangerously low blood sodium and seizures in children than the tablets did. A third use is bleeding. In people with mild hemophilia A or mild to moderate type 1 von Willebrand disease, two inherited bleeding disorders, desmopressin can briefly raise clotting protein levels to cover surgery, dental work or a bleeding episode such as a nosebleed or heavy period. The DDAVP injection and Stimate, a high-strength nasal spray, are the forms used this way. It is not a treatment for severe forms of these disorders. Nocdurna, a tablet dissolved under the tongue for adults who wake two or more times a night to urinate because their bodies make too much urine overnight, is no longer sold in the US.
When the body needs to save water, the pituitary gland releases vasopressin. The hormone acts on receptors in the kidneys called V2 receptors, which let more water pass back into the bloodstream, so the body makes less urine and that urine is more concentrated. Desmopressin acts on the same receptors. Its structure was altered from the natural hormone so that it lasts longer and has very little of vasopressin's effect on blood vessels, which is why usual doses cut urine output without a meaningful rise in blood pressure. For bedwetting, a bedtime dose lowers the amount of urine the kidneys make overnight, so the bladder is less likely to overfill during sleep. For bleeding disorders, desmopressin works through a different effect: it raises blood levels of factor VIII and von Willebrand factor, two proteins the blood needs to form a clot. Levels climb within about 30 minutes and peak at roughly 1.5 to 2 hours, which is why a dose is timed shortly before a procedure. The boost fades over several hours, and doses repeated more often than every 48 hours tend to work less well.
Desmopressin comes as tablets, an oral liquid (Desmoda), nasal sprays and an injection. The doses are not interchangeable: a nasal spray dose is far smaller than a tablet dose, and switching between forms is done with the prescriber, who will set a new starting dose and timing. For diabetes insipidus, the dose is adjusted for each person, usually once to three times a day, until urine output is controlled and sleep is not broken by trips to the bathroom. The oral liquid is measured with an oral syringe and taken on an empty stomach. The standard nasal spray must be primed before first use, delivers only fixed 10 microgram (mcg) sprays and should be thrown away after 50 sprays, because later sprays may deliver too little. A blocked, inflamed or recently operated-on nose can reduce how much is absorbed, so tell the prescriber if this happens. For bedwetting, tablets are taken at bedtime. Drinking should be kept to a minimum from 1 hour before the dose until the next morning (at least 8 hours). Treatment should be paused during an illness with fever, vomiting or diarrhea, and during very hot weather or hard exercise, when children tend to drink more. For bleeding disorders, the injection is given by a clinician, and Stimate is sprayed into one or both nostrils depending on body weight, about 2 hours before a planned procedure. Whether a repeat dose or another treatment is needed is decided by blood tests and how the bleeding responds. Whatever the reason for using it, limiting fluids while desmopressin is working is part of taking it safely, not an optional extra.
Headache, nausea, flushing and mild stomach cramps are the side effects people most often notice, especially at higher doses. The nasal sprays can also cause a stuffy or runny nose, nosebleeds and a sore throat. Some people notice a faster heartbeat or changes in blood pressure, particularly with the injection or high-strength spray. The most important risk is low blood sodium (hyponatremia), which happens when the body holds on to too much water and the blood becomes diluted. Early signs include headache, nausea or vomiting, sudden weight gain, unusual tiredness, restlessness or irritability, and muscle cramps or weakness. Call the prescriber right away if these appear, and do not keep drinking extra fluids. Seizures, marked confusion, hallucinations, being very drowsy or hard to wake, or trouble breathing are signs of severely low sodium and need emergency care: call 911. Serious allergic reactions are rare. Swelling of the face or throat, difficulty breathing or fainting after a dose also needs emergency care right away.
Desmopressin carries an FDA boxed warning, the strongest kind, on its injection about low blood sodium, which can be life-threatening. The same risk applies to every form. It is generally not used in people who have had low sodium before, who have moderate to severe kidney disease, who habitually drink large amounts of fluid, or who have SIADH (a condition in which the body already makes too much antidiuretic hormone). The injection label also rules it out with loop diuretics such as furosemide (strong water pills), with steroid medicines taken by mouth or inhaled, during illnesses such as stomach flu that upset fluid and salt balance, and in heart failure or uncontrolled high blood pressure. Children and adults over 65 are more prone to low sodium and need closer monitoring. Several common medicines make low sodium more likely when combined with desmopressin. These include antidepressants such as SSRIs (selective serotonin reuptake inhibitors, like sertraline) and tricyclics, opioid pain medicines, anti-inflammatory pain relievers such as ibuprofen and naproxen, the seizure medicines carbamazepine and lamotrigine, thiazide water pills, and oxybutynin, a bladder medicine. Tell the prescriber and pharmacist about every medicine, including over-the-counter pain relievers, before starting or changing anything. For people with von Willebrand disease, the exact type matters. Desmopressin should not be used in type 2B, where it can make platelets clump together, lower the platelet count and possibly cause clots, so the type should be confirmed before treatment. Decades of use in pregnancy, mostly for diabetes insipidus, have not shown a clear risk to the baby, and very little passes into breast milk. Anyone pregnant, planning pregnancy or breastfeeding should still review the plan with their care team.
In diabetes insipidus, the first weeks are usually spent finding the dose that controls symptoms without making the body hold on to too much water. Because it replaces a hormone the body is not making, treatment is usually long term. Some people find a dose works less well after long use, and the prescriber may adjust it. Blood sodium is checked before starting and then periodically. The injection label calls for a check within a week and again at about a month, with more frequent checks for people over 65 or taking interacting medicines. Urine volume and how concentrated it is also help show whether the dose is right. For bedwetting, a 2025 review of 95 studies found that children taking desmopressin had about two fewer wet nights a week than with a placebo and were more likely to reach two dry weeks in a row. By the end of treatment, it worked about as well as a bedwetting alarm, though the evidence is of low certainty. Bedwetting often resolves on its own as children grow, so whether treatment is still needed is worth reviewing over time. For bleeding disorders, blood tests confirm the type and severity of the disorder before treatment, and clotting protein levels may be checked afterward to make sure they rose enough. Desmopressin is used for specific procedures or bleeding episodes rather than taken every day.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking DDAVP (Desmopressin), what you've noticed, or ask the community a question.